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Abstract 
Age-related macular degeneration (AMD) is the leading cause of central retinal vision loss 
worldwide, with an estimated 1 in 10 people over the age of 55 showing early signs of the 
condition. While the end stage of wet AMD, namely choroidal neovascularization (CNV) can 
be controlled with regular intravitreal injection of anti-VEGF based medications, there are 
currently no forms of therapy available for the end stage of dry AMD, geographic atrophy 
(GA). Here, we show that the inner blood-retina barrier (iBRB) is highly dynamic and may 
play a central role in GA development. We have discovered that the gene CLDN5, that 
encodes the protein product, claudin-5, a tight junction component abundantly expressed at 
the iBRB, is tightly regulated by BMAL1 and the circadian clock. Persistent suppression of 
claudin-5 expression in mice exposed to a cholesterol-enriched diet induced striking RPE cell 
atrophy and persistent targeted suppression of claudin-5 in the macular region of non-human 
primates induced RPE cell atrophy. These findings implicate an inner retina derived 
component to the early pathophysiological changes observed in AMD and we suggest that 
circadian regulation of claudin-5 at the iBRB allows for replenishment and renewal of 
components of photoreceptor outer segments that are phagocytosed by the retinal pigment 
epithelium (RPE) in a diurnal fashion every day. Our results also suggest that re-establishing 
dynamic claudin-5 cycling at the iBRB may represent a novel therapeutic target for the 
prevention and treatment of GA secondary to dry AMD. 
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Introduction 
Age-related-macular-degeneration (AMD) is the leading cause of central retinal vision loss 
worldwide and it has been estimated that 10 % of people over the age of 55 already show 
early signs of disease. AMD presents in two forms that are generally referred to as either 
"dry" or "wet" AMD (1). The end stage of wet AMD is termed choroidal neovascularisation 
(CNV), where blood vessels sprout from the underlying choroidal vasculature disrupting the 
integrity of the retina and leading to acute vision loss. CNV occurs in approximately 1 in 10 
AMD patients and can be treated with regular intraocular injection of antibodies or fusion 
proteins directed against vascular endothelial growth factor (VEGF) (2). The end stage of 
"dry" AMD is termed geographic atrophy (GA), where the retinal pigment epithelium (RPE) 
begins to degenerate in the region of the macula and can eventually lead to death of cone 
photoreceptor cells and eventually central retinal vision loss (3). There is currently no 
therapeutic for GA other than recommended lifestyle changes such as smoking cessation and 
dietary modification (4). Given the pervasive nature of AMD in the developed world and the 
wealth of research in this area, the underlying molecular pathology associated with GA 
development is still far from clear with the majority of studies to date focused on 
understanding aberrant signalling mechanisms in the RPE. 
The major early pathological hallmark common to both dry and wet AMD is the 
accumulation of drusen between the RPE and the choroid, with reticular pseudodrusen 
depositing in the sub-retinal space in some patients with late AMD and GA. Drusen is 
composed of extracellular components including, but not limited to, amyloid-β, vitronectin, 
cholesterols and almost every complement component (5). These components have all 
previously been identified in several tissues including blood and photoreceptors and it is most 
likely that AMD is primarily a condition that involves aberrant clearance mechanisms.  What 
is less clear however is the source of drusen and the dynamic events that occur during and 
after the diurnal shedding of photoreceptor outer segments (POS) and subsequent 
phagocytosis by the RPE (6).   
On a daily basis, RPE cells phagocytose POS that are shed during renewal of 
photoreceptors (7). While some of the phagocytosed material is recycled to replenish 
essential components of the photoreceptors, other components in the material are exocytosed 
to the basolateral compartment of the RPE and are likely cleared by the systemic immune 
system via the choriocapillaris (8). This is a highly regulated process controlled by 
autophagic and phagocytic processes and dysfunctional rates of clearance are likely a 
significant contributing factor to drusen accumulation in some individuals as evidenced by 
residual-body build up in lysosomes observed in the RPE of AMD donor eyes (9, 10). 
While drusen deposition and localisation differs from individual to individual, it is 
pertinent to consider that there is a considerable degree of symmetry in drusen patterning in 
each eye of a single individual (11, 12). This correlates with an equally high degree of 
interocular symmetry of retinal blood vessels between right and left eyes.  These blood 
vessels which form the inner blood-retina barrier (iBRB) are critical to maintaining retinal 
homeostasis (13, 14).Endothelial cells that line these vessels have evolved tight junctions, a 
series of up to 30 interacting proteins that limit the paracellular space between endothelial 
cells to all but the smallest of molecules. As well as regulating the exchange of ions and 
macromolecules between the blood and the delicate neural microenvironment, these highly 
specialized endothelial cells protect the retina by restricting the entry of potentially damaging 
blood-borne agents such as neurotoxic chemicals, antibodies, pathogens, immune cells and 
anaphylatoxins. They also express a variety of transporters to control both the selective 
transport of nutrients into the retina and the efflux of metabolites and toxins from the retina 
via the transcellular pathway (15, 16, 17, 18). 
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Here, we provide evidence that one of the most enriched tight junction components at 
the iBRB, claudin-5 (19, 20), is under the control of the transcription factor BMAL1 and the 
circadian clock. In addition, regulating its expression can very rapidly lead to a RPE atrophy 
phenotype in pre-clinical mouse and non-human primate models. Our data suggest that 
regulating the dynamic expression pattern of claudin-5 at the iBRB could confer control over 
the delivery and replenishment of the outer segments of photoreceptors and consequently 
control the burden of material consumed by the RPE on a daily basis.  Our findings represent 
the first description of iBRB cycling related to one of the most common forms of central 
retinal blindness. 
 
Results 
The mouse and human retinal pigment epithelium (RPE) is phagocytically active during 
phases of outer segment shedding 
On a daily basis, the effete tips of photoreceptors are shed and phagocytosed by the retinal 
pigment epithelium (RPE). This process happens in a diurnal manner and is stimulated by 
light (21), with active engulfment of outer segments visible in transmission electron 
microscope (TEM) images in the morning when compared to the evening (Fig. 1a). This 
process is accompanied by a surge in autophagic activity in the RPE of mice in the morning 
when compared to the evening (Fig. 1b and c) but can also be re-capitulated by stimulating 
primary human foetal RPE cells with purified outer segments (Fig. 1d). In tandem with an 
increase in transcript levels of autophagic machinery, the RPE cells in vivo appear to exhibit 
pro-inflammatory transcript changes during phases of active phagocytosis which peak in the 
morning and decrease in the evening (Fig. 1e). Given the daily phagocytosis by the RPE of 
material from the POS, it stands to reason that a replenishment process is required to allow 
for outer segment supplementation and restoration. This is clearly a dynamic process and 
while much outer segment material will be recycled within the RPE, a large amount of outer 
segment composition is dietary derived (lipids, cholesterol, docosahexaenoic acid) and must 
be obtained from the diet (Fig 1b). In this regard, the major focus to date has been on 
examining the integrity of the choriocapillaris endothelial cells that are proximal to the 
basolateral aspect of RPE cells (22, 23, 24). In donor AMD eyes with geographic atrophy 
(GA), recent evidence and indeed our own data, indicates a dropout of these CD31+ 
endothelial cells, in areas of atrophic RPE (Fig. 1f). In an effort to explore the integrity of the 
choriocapillaris endothelium in normal adult mouse eyes during phases of active/inactive 
phagocytosis, we observed no differences (Fig. S1) in the morphology/integrity of the 
choriocapillaris endothelial cells.  However, we observed distinct differences in the density of 
the tight junctions associated with the endothelial cells of the inner retina, specifically those 
located in the outer plexiform layer (OPL) (Fig. 1g). While these vessels have not previously 
been reported to be dysfunctional in AMD, their proximity to the RPE, and their similarity to 
the microvasculature associated with the brain, suggests that they may be important for 
selective delivery of material to the neural retina (Fig. 1h). 
 
Size-selective regulation of the inner blood retina barrier (iBRB) mediated by claudin-5 
expression 
Claudin-5 is the most enriched component of both the brain and retinal endothelial tight 
junctions (20). Indeed, its dose dependent expression is critical, with knockout mice dying 
within hours of birth (19, 25). Given our observation of distinct changes in the density of 
tight junctions associated with endothelial cells of the inner retina during the evening (non-
phagocytic activity), we observed significant differences in the levels of expression of 
claudin-5 in the evening compared to the morning at both the protein and transcript level 
(Fig. 2a, **P = 0.0064, and 2b, *P = 0.042). These transcriptional differences in claudin-5 
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expression were confirmed as circadian as opposed to diurnal as dark-adapted (DA) mice 
showed the same pattern of expression (Fig. 2c) as did mice that had their circadian rhythms 
inverted by altering their light cycle (Fig. 2d). While other tight junction components ZO-1 
and occludin appeared to cycle dependent on the time of the day, these did not appear to be 
circadian in nature (Fig. S2).   
Levels of claudin-5 were decreased in the microvasculature of the retina in the 
evening compared to the morning (Fig. 2e and f) and this was accompanied by the increased 
extravasation of a tracer molecule, (EZ-Link-Biotin, 660 Da MW), with enhanced tracer 
signal observed in mice in the OPL and inner/outer segment regions of the retina in the 
evening compared to the morning (Fig. 2g, *P = 0.0184). In mice examined using dynamic 
contrast-enhanced MRI (DCE-MRI), enhanced Gadolinium (800 Da MW) signal was 
observed in the retina in the evening when compared to the morning (Fig. 2h, **P < 0.001) 
and this was also manifested when fundus fluorescein angiograms (FFA) were conducted, 
with enhanced sodium fluorescein (376 Da MW) signal observed in the deeper vascular 
plexus in the evening when compared to the morning (Fig.2i, **P < 0.001). This was also 
observed in other strains of mice including 129SV and CD1 mice (Fig. S3). Intriguingly, this 
circadian change in permeability appeared to be size selective, as no differences were 
observed in FFA analysis using a FITC-labelled dextran molecule of 4 kDa (FITC-Dextran) 
(Fig 2j), suggesting claudin-5 cycling at the iBRB is regulating the passive diffusion of 
molecules below this molecular weight. Unusually, claudin-5 transcripts appeared to cycle in 
an identical manner in all tissues examined, with transcript levels being low in the evening 
and high in the morning in heart and liver (Fig. 2k and l).   
 
Bmal-1 regulates claudin-5 levels in mouse and human retinal endothelial cells 
Bmal-1 is a transcription factor that is an essential component of the circadian clock (26).  
The promoter regions of both mouse and human claudin-5 contain E-box sequences that act 
as Bmal-1 protein binding sites and can regulate claudin-5 expression (Fig. 3a). Indeed, in 
mice with a targeted disruption of Bmal-1 expression in the vascular endothelium 
(Bmal1f/f.Tie2-Cre), levels of claudin-5 protein remained un-changed in the retinas of mice 
between the morning and evening (Fig. 3b) and this effect was observed at the transcript 
level even in mice lacking only a single Bmal-1 allele in the retinal endothelium (Fig. 3c).  
The levels and pattern of expression of claudin-5 appeared the same in retinas of 
Bmal1f/f.Tie2-Cre mice (Fig. 3d and e) and there was no difference between FFA performed 
in these mice between the morning and evening (Fig. 3f and g). This phenotype was also 
observed in mice with a single Bmal1 allele remaining, namely Bmal1WT/f.Tie2-Cre (Fig. S4).  
TEM images of the tight junctions associated with the endothelium of microvessels in the 
OPL showed no difference in the morning compared to the evening in Bmal1f/f.Tie2-Cre mice 
(Fig. 3h). 
Cells in vitro do not have an entrained circadian rhythm; however, rhythmicity can be 
induced by serum shocking cells with 50% serum for 2 hours (27). Primary human retinal 
endothelial cells were exposed to a serum shock and claudin-5 levels were observed to cycle 
in manner identical to that observed in mice (Fig. 3i). However, RNAi-mediated suppression 
of the expression of BMAL1 in human retinal endothelial cells prior to serum shock showed a 
cessation of claudin-5 cycling (Fig. 3j and 3k) that was accompanied by a decrease in Trans-
Endothelial Electrical resistance (TEER) and a discontinuous pattern of expression at the 
plasma membrane of cells (Fig. 3l and m). 
 
Targeted suppression of claudin-5 with a high cholesterol diet induces RPE atrophy  
It is well established that environmental factors such as smoking and a high fat/cholesterol 
diet are major risk factors for AMD. In that regard, and to determine whether a ‘Western’  
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diet could induce RPE atrophy, we fed adult C57BL/6J mice a high fat diet for 3 months. 
These mice weighed almost double the weight of mice kept on a normal diet and were nearly 
3 times heavier than mice kept on a calorie-restricted diet (Fig. 4a and 4b). While there was 
a decrease in the levels of claudin-5 observed in the retinas of mice on a high fat diet and a 
calorie restricted diet (Fig. 4c), there was no observable difference in the integrity of the RPE 
in these mice (Fig. 4d). Next, to re-capitulate a persistent phenotype similar to that observed 
in wild-type mice in the evening (i.e., high sodium fluorescein signal), we sub-retinally 
injected an adeno-associated virus (AAV9) vector expressing claudin-5 shRNA under the 
control of a doxycycline-inducible promoter. A non-targeting (NT) AAV9 vector expressing 
doxycycline inducible shRNA targeting the non-mammalian gene luciferase was used as a 
control. Mice were fed a high cholesterol diet as described previously and doxycycline was 
supplemented in the drinking water. Within 3 weeks of constant claudin-5 suppression, 
enhanced sodium fluorescein extravasation was observed in mice fed a normal diet (Fig. 4e, 
top panels).  However, in mice with suppressed claudin-5  fed a high cholesterol diet (28), 
enhanced fluorescein signal was observed in the deeper vascular plexus with apparent hyper-
reflectivity of the underlying RPE (Fig. 4e, bottom panels). Analysis of histological sections 
of the retina showed enlarged, vesiculated/vacuolated RPE cells that contained a large 
amount of auto-fluorescent material (Fig. 4f). Analysis of flatmounts from eyes of these mice 
stained for the tight junction component ZO-1 showed regions of atrophic AMD where the 
underlying choroid was visible (Fig. 4g). As claudin-5 is not expressed in the RPE, and the 
AAV will transduce endothelial cells only within the retinal side of the outer blood-retina 
barrier (oBRB), this data is strongly suggestive of the passive paracellular diffusion of 
material from the systemic circulation towards the RPE. (Fig. 4h). In order to suppress 
claudin-5 in both the retina and the choriocapillaris, we developed a mouse model that would 
allow us to inducibly suppress claudin-5 throughout the whole body (Fig 4i, j and k). A 
similar phenotype was  observed in these mice with a targeted “knockin” of claudin-5 
shRNA, with enlarged and vesiculated RPE cells observed (Fig 4l) in mice with decreased 
levels of claudin-5 fed a cholesterol rich diet. The concomitant decrease in the RPE derived 
C-wave signal (Fig. 4m), suggests the phenotype is derived from the inner retinal vasculature 
as opposed to the choroidal vasculature. 
Surprisingly, using an AAV based method to over-express claudin-5 in the retinal 
endothelium an identical phenotype was observed as when we suppressed expression, even in 
the absence of a cholesterol rich diet (Fig 4n and o), re-enforcing the concept that circadian 
entrained BMAL1 dependent cycling of claudin-5 is critical to the health and integrity of the 
RPE. 
 
Targeted suppression of claudin-5 in the primate retina can induce RPE atrophy 
While the use of mouse models of disease has added greatly to our understanding of human 
conditions, it must be recognised that mice lack a cone rich macula similar to the human 
retina. Therefore, we designed an AAV expressing a doxycycline inducible shRNA targeting 
a homologous region of the human and African Green monkey claudin-5 mRNA. Three 
monkeys were injected sub-retinally in the macular region with this AAV and were 
supplemented with doxycycline in their diet. Within 2 weeks, we observed hyper-reflectivity 
in optical coherence tomography (OCT) measurements that were commensurate with atrophy 
observed in AMD patients and this was concomitant with enhanced sodium fluorescein 
leakage at the site of sub-retinal injection (Fig 5a, b and c). This phenotype was confirmed 
by OCT and histological analysis of retinal cryosections of this region (Fig 5d and e). 
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Discussion 
Here, we describe for the first time, an inner retina derived contribution to RPE cell atrophy.  
Our series of observations could have major implications for the prevention of AMD in 
general and more specifically in the prevention of geographic atrophy (GA) secondary to dry 
AMD. 
We have shown that the major iBRB associated tight junction component, claudin-5, 
cycles in a distinct circadian rhythm and is regulated by the circadian clock component 
BMAL1. Claudin-5 is one of the central mediators of paracellular passive diffusion of 
material from blood to retina and vice-versa and appears to be a critical factor in allowing for 
the daily passive diffusion of dietary material from the blood to the retina (13, 14). In this 
regard, we have shown that size-selective passive diffusion of systemically injected tracer 
molecules will move from the inner retinal vasculature into the retinal parenchyma and 
diffuse towards the outer retina and RPE. This is important as an inner retina derived supply 
of material to photoreceptor outer segments and RPE has not been described previously and 
may represent a critically important physiological process central to the development of 
AMD. 
We have shown that chemical and genetic ablation of Bmal-1 function can prevent 
claudin-5 cycling and impact the integrity of primary human retinal endothelial cells.  It is of 
note that BMAL1 mediated circadian rhythmicity is dysregulated in the aged population (29, 
30, 31) and it is tempting to suggest aberrant claudin-5 cycling in the human retina with age 
is a contributing factor to drusen accumulation and subsequent RPE atrophy. 
It is well known that poor diet and smoking are major risk factors for AMD (32).  
However, we found that a high fat diet alone or indeed a calorie-restricted diet was not 
sufficient to induce an RPE phenotype in mice even after 15 weeks of dietary 
supplementation. Additionally, we found that simply producing more claudin-5 protein 
expression at the inner retina is insufficient to protect against RPE atrophy and actually 
induced RPE atrophy and retinal thinning. This suggests that the process of claudin-5 cycling 
at distinct times of the day, aligned with POS replenishment, is critical in maintaining RPE 
health and integrity.   
For the treatment of CNV secondary to wet AMD and GA secondary to dry AMD, 
retinal translocation surgical procedures were previously undertaken in an effort to restore 
visual acuity in patients by surgically translocating the neural retina from the atrophic RPE 
affected area to a region of intact RPE cells. While these techniques represented advanced 
and technically demanding surgeries, they proved successful for a sub-group of patients with 
sub-foveal CNV. It was of note however, that up to 47% of patients exhibited RPE atrophy in 
the translocated region within 45 months of surgery, suggesting an inner retina derived 
process that could promote RPE cell stress and death (33, 34). Interestingly, iBRB breakdown 
has been related to a rare juvenile retinal condition, Coats' disease, where leakage of blood 
derived cholesterol crystals and lipid-laden macrophages infiltrate the sub-retinal space. The 
pathophysiology of this condition lends weight to an inner retinal vascular derived deposition 
of material towards the RPE (35). We therefore propose a circadian entrained cycling of the 
permeability of the inner retinal vasculature as a key contributing factor to a dynamic retinal 
interstitial kinesis that allows for replenishment of substrate to the photoreceptor’s for outer 
segment renewal. In the ageing eye, with dysregulation of the circadian clock, we propose 
that this process ceases to be regulated and therefore will either deprive or overload the RPE 
with essential metabolites  leading to drusen deposition and eventual RPE atrophy. Overall, 
our observations directly implicate claudin-5 as a key mediator of disease pathology in AMD 
and suggest that methods aimed at restoring the dynamic expression of this molecule in the 
ageing eye may prevent or indeed halt the progression of AMD. 
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Methods 
Animal Experiments and Experimental groups 
All studies carried out in the Smurfit Institute of Genetics in TCD adhere to the principles 
laid out by the internal ethics committee at TCD and all relevant national licences were 
obtained prior to commencement of all studies. C57/Bl6J were sourced from Jackson 
Laboratories and bred on-site at the Smurfit Institute of Genetics in TCD. Prior to 
experiments, all mice were kept on a 12 h light/dark cycle with lights on at 8 am and lights 
off at 8 pm. For experiments involving inversed cycles, mice were kept on a light/dark cycle 
with lights on at 8 pm and lights off at 8 am for a minimum of 3 weeks. 
 
Transmission electron microscopy 
Eyes were immersion fixed in 2.5% glutaraldehyde in 0.1M phosphate buffer, pH 7.2 reagent 
overnight and washed 3 times with EM grade Phosphate buffered saline (PBS).  Eyes were 
embedded in resin and 1um sections were prepared using a diamond blade.   
 
qPCR arrays 
The mouse autophagy RT2 Profiler PCR Array (Qiagen) was used to profile 84 autophagy-
related genes. cDNA synthesis was carried out using the RT2 First Strand Kit according to 
manufacturer’s instructions. First, genomic DNA was removed with the genomic DNA 
elimination mix. For the reverse transcription step, the following reaction was prepared: 4 µl 
of 5X Buffer BC3, 1 µl Control P2, 2 µl RE3 Reverse Transcriptase Mix, 3 µl RNase-free 
water. 10 µl of the reverse transcription mix was mixed with 10 µl of the genomic DNA 
elimination mix and incubated for 15 min at 42oC and immediately for 5 min at 95oC. Each 
reaction was mixed with 91 µl of NF H2O and placed on ice. RT-PCR was carried out using 
the RT2 SYBR Green Mastermix by mixing the following: 1350 µl 2x RT2 SYBR Green 
Mastermix, 102 µl cDNA synthesis reaction, 1248 µl RNase-free water. 25 µl was added to 
each well of the RT2 Profiler PCR Array and the plate was sealed with optical adhesive film. 
The plate was centrifuged for 1 min at 1000 g and placed into a StepOne PlusTM Real-Time 
PCR instrument. RT-PCR conditions were as follows: 95oC for 10 min; 40 cycles of 95oC for 
15 s, 60oC for 1 min. A melt-curve stage was added of: 95oC for 15 s, 60oC for 1 min, 95oC 
for 15 s. The absolute quantitation method was used to quantify changes in mRNA levels 
between treatment groups. 
 
Haemotoxylin and Eosin (H&E) staining 
Paraffin sections were deparaffinised by dipping 10 times in xylene followed by rehydration 
in 10 dips each of 100 %, 90 % and 70 % ethanol. Slides were incubated in haemotoxylin 
solution for 6 min, rinsed in water, and then incubated in eosin solution for 2 min. Slides 
were rinsed in water and dehydrated by dipping 10 times in 70 %, 90 %, 100 % ethanol and 
once in xylene. Coverslips were placed on slides using Sub-X Mounting Medium. Slides 
were analysed under a light microscope (Olympus 1X81). 
 
Indirect immunostaining of retinal flatmounts and retinal cryosections 
Mouse retinal cryosections (12 µm thick) were fixed with methanol for 10 min at -20oC, 
washed twice in PBS and blocked/permeabilised with 5% normal goat serum (NGS), 0.5% 
Triton X-100 in 1X PBS for 30 min at room temperature. Sections were incubated with 
primary antibodies (rabbit anti-mouse claudin-5; rabbit anti-mouse ZO-1; rabbit anti-mouse 
CD31 (1:100)) at 4oC overnight. Sections were washed 3 x 5 min in PBS and incubated with 
fluorescently labelled secondary antibodies (goat anti-rabbit Cy3, goat anti-rabbit Cy2 
(1:500)) for 2 h at room temperature followed by 3 x 5 min washes with PBS. To label blood 
vessels, sections were co-stained with Isolectin-IB4 Alexa Fluor 488 (1:300). All sections 
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were counterstained with Hoechst 33258 (1:10,000) for 30 seconds and mounted with Aqua 
Poly/Mount (Polysciences, Inc). Images were acquired using a Zeiss LSM 710 confocal laser 
scanning microscope. Identical acquisition settings were used to acquire images and image 
processing was performed in Adobe Photoshop and ImageJ.  
 
Western blot analysis 
Retinal tissue and cells were lysed in RIPA lysis buffer with phosphatase and protease 
inhibitors (Sigma), incubated on ice for 10 min and centrifuged at 12,000g at 4oC for 20 min. 
10 µg of protein were resolved on 12 % SDS polyacrylamide gels. Proteins were transferred 
to PVDF membranes and blocked for 1 h at room temperature in 5 % non-fat milk and tris-
buffered saline containing 0.1 % Tween-20 solution (TBST). Membranes were then 
incubated with primary antibodies against claudin-5 (1:1000), Bmal-1 (1:1000) and β-actin 
(1:5000) overnight at 4oC, washed 2 x 5 min in TBST and incubated with HRP-conjugated 
goat anti-rabbit secondary antibody (1:5000) for 2 h at room temperature. After 4 x 10 min 
washes in TBST, protein bands were visualised using enhanced chemiluminescence (ECL; 
Advansta) with an image analyser (LI-COR C-DiGit scanner). Densitometry was performed 
using ImageJ with protein bands of interest normalised to the loading control β-actin. 
 
qPCR analysis 
RT-PCR was carried out using a SensiFAST SYBR Hi-ROX Kit (Bioline) according to 
manufacturer’s instructions. PCR was performed in a Step-One PlusTM Real-Time PCR 
instrument (Applied Biosystems). RT-PCR conditions were as follows: 95oC for 10 min; 37 
cycles of 95oC for 15 s, 60oC for 30 s. A melt-curve stage was added: 95oC for 15 s, 60oC for 
1 min, 95oC for 15 s. The comparative CT method was used to quantify changes in mRNA 
levels between treatment groups. The following primers were designed using Primer3. 
 
 Claudin-5 F 5’ TTTCTTCTATGCGCAGTTGG 3’ 
   R 5’ GCAGTTTGGTGCCTACTTCA 3’ 
 Occludin F 5’ ACAGTCCAATGGCCTACTCC 3’ 
   R 5’ ACTTCAGGCACCAGAGGTGT 3’ 
 Zo-1  F 5’ CCACCTCTGTCCAGCTCTTC 3’ 
   R 5’ CACCGGAGTGATGGTTTTCT 3’ 
 Bmal-1 F 5’ ATCAGCGACTTCATGTCTCC 3’ 
   R 5’ CTCCCTTGCATTCTTGATCC 3’ 
 β-actin  F 5’ TCACCCACACTGTGCCCATCTACGA 3’ 
   R 5’ CAGCGGAACCGCTCATTGCCAATGG 3’ 
 
Biotin permeability assay 
Mice were injected iv through the tail vein with 2 mg/ml of EZ-LinkTM Sulfo-NHS-Biotin 
(600 Da). Eyes were enucleated 5 min post-biotin injection and immersion fixed in 4 % 
paraformaldehyde (PFA, pH 7.4) overnight at 4oC. Eyes were cryoprotected by sequential 
incubations in 10%, 20%, 30% sucrose and frozen in OCT freezing media. Mouse retinal 
cryosections were incubated with Cy3-conjugated streptavidin (1:200) overnight at 4oC to 
label Sulfo-NHS-Biotin. Biotin leakage was visualised with a Zeiss LSM 710 confocal laser 
scanning microscope. Image analysis was performed in ImageJ by drawing regions of interest 
outside of blood vessels and measuring the mean pixel intensity.   
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Circadian/dark adaptation/inversion experiments 
C57BL/6J, Bmal1wt/wt.Tie2-Cre, Bmal1wt/f.Tie2-Cre and Bmal1f/f.Tie2-Cre mice housed on a 
normal light/dark cycle, inverted light/dark cycle or constant darkness for 24 h were 
sacrificed at 8AM and 8PM and retinas removed for protein and RNA analysis. 
 
Circadian/dark adaptation/inversion experiments 
C57BL/6J, Bmal1wt/wt.Tie2-Cre, Bmal1wt/f.Tie2-Cre and Bmal1f/f.Tie2-Cre mice housed on a 
normal light/dark cycle, inverted light/dark cycle or constant darkness for 24 h were 
sacrificed at 8AM and 8PM and retinas were removed for protein and RNA analysis. 
 
Magnetic Resonance Imaging (MRI) 
iBRB integrity was assessed in vivo via MRI, using a dedicated small rodent 7 T MRI system 
located at TCD (www.neuroscience.tcd.ie/technologies/mri.php).  Anaesthetised mice were 
physiologically monitored (ECG, respiration and temperature) and placed on an MRI-
compatible support cradle, with a built-in system for maintaining the animal’s body 
temperature at 37C.  The cradle was then positioned within the MRI scanner.  Accurate 
positioning was ensured by acquiring an initial rapid pilot image, which was then used to 
ensure the correct geometry was scanned in all subsequent MRI experiments.  T1 weighted 
MR images (resolution, 0.156 X 0.156 X 5 mm3; field of view: 20 X 20 X 17.9 mm3; matrix; 
128 X 128 X 30; TR/TE: 500/2.7 ms; flip angle: 30o; number of averages: 3; acquisition time: 
2 min, 24 sec; Repetitions: 12) following administration of 100 µl of a 1 in 3 dilution of Gd-
DTPA (Gadolinium diethylene-triamine penta-acetic acid), administered via the tail vein.  A 
quantitative assessment of iBRB integrity was also made using dynamic contrast enhanced 
(DCE) MRI, in which the passage of Gd-DTPA from the vasculature into the tissue was 
monitored over a period of 10 minutes post-injection (referred to above as "bolus chase 
analysis").   
 
AAV2/9 design and generation 
Short hairpin RNAs (shRNAs) designed to target transcripts derived from mouse claudin-5 
were incorporated into AAV-2/9 vectors. Claudin-5 shRNA was cloned into the pSingle-tTS-
shRNA (Clontech) vector, which uses a doxycycline inducible promoter. The plasmid 
incorporating the inducible system with claudin-5 shRNA was digested with BsrBi and BsrGI 
and ligated into the Not1 site of the plasmid pAAV-MCS, such as to incorporate left and right 
AAV inverted terminal repeats (L-ITR and R-ITR). AAV-2/9 was then generated using a 
triple transfection system in a stably transfected Hek293 cell line for the generation of high-
titre viruses (Vector BioLabs). In a similar manner, mouse claudin-5 cDNA was cloned into 
the genome of an AAV-2/9 vector for over-expression of claudin-5. 
 
Cldn5 knockdown mouse generation 
Mice were generated by standard blastocyst injection (Nagy et al., 2003) at Charles Rivers 
Laboratory in collaboration with Mirimus Inc. using their strict VAF/EliteTM health 
standards. A doxycycline-inducible claudin-5 shRNA was knocked in at the Col1a1 locus on 
chromosome 11. Additionally, a CAG-lox-stop-lox-rtTA3-IRESmKate2 (CLR3K) allele was 
knocked in at the Rosa26 locus on chromosome 6. Mice homozygous for the claudin-5 
shRNA containing gene and the reverse tetracycline-controlled transactivator (rtTA) gene 
were crossed to Tie-2-Cre expressing animals for endothelial-specific expression of claudin-5 
shRNA. Cre-negative littermate mice were used as controls. Doxycycline was administered 
to the drinking water (2 mg/ml in 2% sucrose solution) to activate shRNA expression and 
replenished three times a week. 
 
  10 
FFA and OCT analysis 
FFA and OCT was performed on mice using a Heidelberg Spectralis™ OCT (Heidelberg 
Engineering, Heidelberg, Germany). Pupils were dilated with 1% tropicamide and 2.5% 
phenylephrine and mice anaesthetized using a mixture of ketamine and domitor. Mice were 
intraperitoneally injected with sodium fluorescein (2 mg/ml) at same volume/weight 
(100µl/20g) to visualize the blood vessels. For size selectivity study, mice were injected with 
the same volume/weight of FITC-Dextran FD4 (Sigma, 2mg/m) in a similar fashion to 
sodium fluorescein. FFA images were captured from 2 min to 10 min every 30 s. FFA and 
OCT images were captured with a 30-degree angle of view.  Heidelberg eye explorer version 
1.7.1.0 was used to capture images. For quantification of microvessel permeability ImageJ 
was used for analysis.  
 
RNAi experiment  
Brain endothelial cells (bEnd.3) were transfected with 10 pmol non-targeting (NT) or Bmal-1 
siRNA using Lipofectamine® 2000 transfection reagent (ThermoFisher Scientific) diluted in 
OptiMEM reduced serum media according to manufacturer’s instructions. 48 h post-
transfection, media was replaced with media containing 50 % foetal calf serum and cells were 
shocked for 2 h. Following serum shock, cells were incubated in serum-free media and 
protein lysates were collected every 4 h for 28 h. 
 
Immunocytochemistry 
Confluent bEnd.3 cells were washed twice in PBS and fixed with 4% PFA for 10 min at room 
temperature. Following fixation, cells were washed twice with PBS and 
blocked/permeabilised with 5% NGS, 0.05% Triton X-100 in PBS for 1 h at room 
temperature. Cells were incubated in primary antibody against claudin-5 (1:100) overnight at 
4oC. Cells were washed three times with PBS and incubated with goat anti-rabbit Cy3 (1:500) 
secondary antibody for 2 h at room temperature, followed by four washes with PBS. Nuclei 
were stained with Hoechst 33258 (1:10,000). The slide was removed from the chamber and 
mounted with Aqua Poly/Mount (Polysciences, Inc) before visualisation by confocal laser 
scanning microscopy. 
 
Transendothelial electrical resistance (TEER) 
TEER measurements were performed on cells grown on 6.5 mm diameter 0.4 µm pore 
polyester membrane HTS transwell inserts (Corning Costar). TEER values were measured 
using an EVOM resistance meter fitted with “chopstick” electrodes. Prior to measurements, 
the apical and basolateral chambers were replaced with fresh medium. TEER values were 
recorded in triplicate and the average value of a no cell compartment was subtracted from the 
average of the triplicate measurements. TEER values were expressed as ohm*cm2 (Ω.cm2). 
 
High fat and high cholesterol diet study 
C57Bl/6J mice were either given a high cholesterol diet (Envigo, TD.88051) or high fat 
(western) diet [Rodent diet with 45% kcal% fat, (Research Diets, Inc D12451)]. 
 
Electroretinography 
Mice were dark-adapted overnight and prepared for electroretinography under dim red light. 
Pupils were dilated with 1 % cyclopentalate and 2.5 % phenylephrine. Animals were 
anaesthetised by i.p. injection of ketamine and xylazine. Standardised flashes of light were 
presented to the mice in a Ganzfeld bowl to ensure uniform retinal illumination. ERG 
responses were recorded simultaneously from both eyes using gold wire electrodes (Roland 
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Consulting Gmbh) and Vidisic (Dr Mann Pharma. Germany) as a conducting agent and to 
maintain corneal hydration. 
 
Non-human primate study 
Pupils were be dilated with 1% tropicamide and 2.5% phenylephrine hydrochloride drops.   
Subretinal injections of AAV expressing claudin-5shRNA under the control of a doxycycline 
inducible promoter were be performed under a surgical microscope in 3 African Green 
monkeys in a sterile surgical field under aseptic conditions.  After placement of a lid 
speculum, a radial conjunctival peritomy incision was made in the superior temporal quadrant 
and a pars plana sclerotomy site marked on the sclera.  A sclerotomy incision was be made at 
the marked location using a 25-gauge MVR knife.   After an anterior chamber paracentesis by 
30-gauge needle at the limbal cornea, and application of a contact lens coupling solution, a 
Machemer fundus contact lens was placed on the cornea.  A 30-gauge anterior chamber 
cannula, employed as a sub-retinal injector, was then introduced through the superior 
temporal sclerotomy into the vitreous cavity under the operating microscope.  The cannula 
was then be maneuvered so that it was apposed to the posterior temporal retinal surface at an 
oblique angle. The cannula was advanced to catch a fold of retina on the cannula tip and then 
advanced further to pierce the retina, avoiding injury to the underlying RPE and choroid. 
AAV was then injected in a small volume to confirm position and patency of the cannula tip. 
Once confirmed the total target volume of 100 L of CLDN5 AAV-2/9 or control vector was 
injected, with monitoring of the injection under direct visualization through the microscope.  
The cannula was then removed from the retina and scleral insertion site.  Tobramycin and 
dexamethasone ointment (Tobradex) was administered topically following the injection 
procedure. 
 
Non-human primate (NHP) fluorescein angiography 
Fundus colour photography and angiography was  performed on anesthetized animals using a 
retinal camera (model TRC 50X; Topcon America Corp., Paramus, NJ) with Canon D4 
digital imaging hardware and New Vision Fundus Image Analysis System software.  
Fluorescein angiography in the left eye was preceded by angiography in the right eye by 6 
hours to allow adequate time for wash out of fluorescein between image series.  Colour and 
red-free images were collected from each eye prior to infusion of 0.1 mL/kg 10% sodium 
fluorescein into the saphenous vein.  A rapid series of angiogram images were collected from 
the posterior pole immediately after completion of the infusion for the first minute, and then 
at 2, 3 and 6 minutes.  A single angiogram was also taken from the contralateral eye after 
collection of the 6-minute angiogram image to ensure inter-eye consistency in fluorescein 
levels in the optic nerve head and normal vasculature.  Colour and red-free photographs and 
fluorescein angiograms were collected from each animal at 14 days post injection.  
 
NHP OCT examinations   
OCT was performed employing a Heidelberg Spectralis OCT Plus with eye tracking and 
HEYEX image capture and analysis software.  Images were acquired from all the eyes at 
baseline, immediately post-injection and at 14 days (immediately pre-sacrifice).  At all time 
points an overall volume scan of the entire macula was performed at a dense scan interval, 
encompassing the sub-retinal injection site where applicable. 
 
NHP termination   
On day 14 post-injection monkeys were euthanized by pentobarbital overdose while under 
ketamine sedation and globes enucleated.  Globes were marked at the 12’00 position with 
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indelible ink prior to enucleation.  Eyes were prepared embedding and sectioning by fixing in 
Davidson’s fixative for 24 hours. 
 
Statistical Analyses 
Statistical analysis was performed using Student’s T-test, with significance represented by a 
P value of ≤0.05 when 2 individual experimental groups were being analysed.  For multiple 
comparisons, ANOVA was used with a Tukey-Kramer post-test and significance represented 
by a P value of ≤0.05.     
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Legends 
Figure 1 
a)  Transmission electron microscopy (TEM) of mouse retina and retinal pigment epithelium 
(RPE) at 8AM (left panel) showing effete tips of rod photoreceptor cells being phagocytosed 
(red arrows) compared to 8PM (right panel). Choriocapillaris (CC), outer segments (OS). b) 
Schematic representation of increased autophagy and inflammatory gene transcripts during 
active phagocytosis in the morning (left panel) compared to the evening (right panel).  
Yellow arrows indicate directionality of material transfer across the luminal and abluminal 
surfaces of the RPE. c) Significantly increased levels at 8AM compared to 8PM of autophagy 
related genes caspase-8, Hsp90aa1, Gabarapl2, Bak1, Hsc70, Nfkb1, Gaa, Bad, Dram2, 
p27Kip1, Gabarap, Ctsd, Atg12, Rgs19 and Atg 5. (n = 3 independent experiments). d) Post 
stimulation of primary RPE cells with photoreceptor outer segments (POS) induced 
significant increases in P53, Nfkb1, Hsp90aa1, Sqstm1, Dapk1, Atg4c, Npc1, Atg1612, Bcl2, 
Bid, Tgfb1, Ulk2, Casp8, Ctsb, Hspa8. e) Significant changes at 8AM compared to 8PM of 
the inflammation-related genes Panx1, Pea15a, Hsp90aa1, Tak1, Il1b, Tnf, Erk2, Sugt1, Ctsb, 
Jnk2, Nfkb1, Ikk1, Il18, Caspase-8 and Mal. (n = 3 independent experiments). f) CD31 
(green) staining in non-diseased age matched donor eye (left panel) and advanced age related 
macular degeneration (AMD) with geographic atrophy (GA) (right panel). g) TEM images of 
retinal vessels in the mouse outer plexiform layer (OPL) at 8AM (left panels-top and bottom) 
and 8PM (right panels-top and bottom). Red arrow indicates endothelial cell tight junction. 
Lumen (L). h) Schematic of retinal blood vessel tight junction and retina histology.  
 
 
Figure 2 
a) Western blot analysis of claudin-5 expression at 8AM compared to 8PM. Densitometric 
analysis (right panel, **P = 0.0064). (n = 5 for each time point). b) qPCR base analysis of 
claudin-5 transcript decreased at 8PM compared to 8AM (*P = 0.042, n = 5 mice for both 
time points). c) Transcript levels decreased at 8PM compared to 8AM in mice dark-adapted 
(DA) for 24 hrs (*P = 0.0483, n = 5 mice for DA-AM and n = 4 mice for DA-PM). d) 
Decreased levels of claudin-5 transcript in mice with inverted circadian rhythm (*P = 0.0235, 
n = 3 mice for AM, n = 4 mice for inverted). e) Claudin-5 (red) levels in the retinas of mice at 
8AM (left panel) compared to 8PM (right panel), outer nuclear layer (ONL), inner nuclear 
layer (INL), ganglion cell layer (GCL). f) High magnification images of claudin-5 (red) in the 
retinas of mice at 8AM (left panel) compared to 8PM (right panel). g) EZ-Link-Biotin (red) 
extravasation in the inner and outer segments of the photoreceptors at 8PM compared to 
8AM. Retinal vasculature stained with isolectin IB4 (green). h) Significantly enhanced 
Gadolinium (800 Da MW) extravasation in the retina of mice at 8PM (right panel) compared 
to 8AM (left panel). Dynamic contrast-enhanced MRI (DCE-MRI)-right panel histogram, 
***P < 0.001 (n = 5 mice for AM, n=4 mice for PM). i) Fundus fluorescein angiography 
(FFA) 3, 5 and 10 min post sodium fluorescein (MW: 376 Da) injection at 8AM (top panel) 
compared to 8PM (bottom panel), with enhanced signal at 8PM (***P < 0.001, n = 5 mice for 
both time points). j) FFA analysis of FITC-Dextran-4 (FD-4) (MW: 4,000 Da) at 8AM (top 
panel) compared to 8PM (bottom panel) (n = 8 for both time points). k) Significantly 
decreased levels of claudin-5 transcript in the heart at 8PM (*P = 0.0393) compared to 8AM 
and i) the liver (*P = 0.0386) (n = 3 for both time points). 
 
Figure 3 
a) E-box sequences in the promoter region of mouse and human claudin-5. b) Claudin-5 
expression at 8AM and 8PM in Bmal1f/f.Tie2-Cre+ mice at 8AM compared to 8PM (n=5 for 
both time points, P= ns). c) Claudin-5 transcript levels in WT.Cre+, Bmal1WT/fTie2.Cre+ and 
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Bmal1f/fTie2.Cre+ mice. d) Claudin-5 expression in retinas of Bmal1f/fTie2.Cre+ at 8AM (left 
panel) compared to 8PM (right panel), e) higher magnification. f) Fundus fluorescein 
angiography (FFA) in Bmal1f/fTie2.Cre+ at 8AM (top panel) compared to 8PM showed g) no 
significant differences. (n = 12 mice for 8AM and n = 11 mice for 8PM) h) Transmission 
electron microscopy (TEM) analysis of tight junction integrity in Bmal1f/fTie2.Cre+ at 8AM 
compared to 8PM, Lumen (L). i) Claudin-5 expression in primary human retinal endothelial 
cells (HRECs) exposed to serum shock (50% serum) for 2 hours. j) Suppression efficacy of 
Bmal-1 siRNA on Bmal-1 transcript expression (*P = 0.0026, n = 3). k) Claudin-5 expression 
in bEnd3 cells with suppressed Bmal1 prior to serum shock exposure. l) Trans-endothelial 
electrical resistance (TEER) measurement in bEnd3 cells with Bmal1 suppressed (*P 0.0339, 
n = 5). m) Claudin-5 staining in bEnd3 cells post suppression of Bmal1. Claudin-5 (red), 
nuclei (green). Scale bar – 50 µm. 
 
Figure 4 
a) Mice fed a calorie restricted (CR) diet, normal diet (ND) or high fat diet (HFD). b) Body 
weights of mice on CR, ND and HFD. c) Claudin-5 transcript levels in mouse retinas from 
mice on CR, ND or HFD (n = 5 mice for CR, n = 7 mice for ND/HFD, ANOVA *P=0.046). 
d) Retinal histology of mice fed a ND or a HFD. e) Fundus fluorescein angiography (FFA) in 
mice injected with a non-targeting shRNA AAV2/9 and fed a ND (top left panel), or HFD 
(bottom left panel). FFA analysis of mice injected sub-retinally with a claudin-5 targeting 
shRNA AAV2/9 and fed a ND (top right panel) or a HFD (bottom right panel). f) Retinal 
histology of mouse injected sub-retinally with a non-targeting shRNA AAV2/9 and fed a 
HFD (left panel) or claudin-5 targeting shRNA AAV2/9 and fed a HFD. DAPI (blue), 
autofluorescence (red), RPE: retinal pigment epithelium, ONL: outer nuclear layer, OPL: 
outer plexiform layer, INL: inner plexiform layer. g) ZO-1 (green) staining in flatmounts of 
mice receiving AAV2/9.NTshRNA sub-retinally (left panel) or AAV2/9.CL5shRNA (right 
panel), (n = 4 mice). h) Schematic representation of retinal interstitial kinesis (RIK). Normal 
paracellular flux of blood-derived components towards the RPE (left panel). Aberrant flux of 
material from the inner retina inducing RPE atrophy. i)  FFA analysis in Cldn5.Tie2-Cre- 
mice (left panel). FFA analysis in Cldn5.Tie2-Cre+ mice (right panel). j) Quantitative 
analysis of fluorescein leakage in Cldn5.Tie2-Cre+ mice (***P < 0.001, n = 7 mice for 
Cldn5.Tie2Cre-, n = 8 mice for Cldn5.TieCre+). k) Claudin-5 (blue) expression in 
Cldn5.Tie2-Cre- mice (left panel) compared to Cldn5.Tie2-Cre+ mice (right panel). IB4 
(green). l) Retinal histology in Cldn5.Tie2-Cre- mice fed a HFD (left panel) compared to 
Cldn5.Tie2-Cre+ mice fed a HFD (right panel), DAPI (blue). m) C-wave elecroretinography 
analysis in Cldn5.Tie2-Cre- mice compared to Cldn5.Tie2-Cre+ mice (n = 7 mice). n) FFA 
analysis in mice injected sub-retinally with saline (top panels) compared to mice injected sub-
retinally with a CMV-mCldn5 expressing AAV2/9 (bottom panels). o) Optical coherence 
tomography (OCT) analysis of control mice (top panel) compared to mice injected with 
AAV2/9.CMV.mCldn5 (n = 10 mice). 
 
Figure 5 
a) Retinal fundus photograph from African Green monkey pre-injection and b) 3 weeks post 
sub-retinal injection of claudin-5 targeting shRNA AAV2/9. c) Fundus fluorescein 
angiography (FFA) 3 weeks post sub-retinal injection of claudin-5 targeting shRNA AAV2/9. 
d) Optical coherence tomography (OCT) analysis of AAV2/9 injected eye. ILM: Inner 
limiting membrane, BM: Bruch’s membrane). e) Histological analysis of retina injected with 
AAV2/9 expressing claudin-5 targeting shRNA (n  = 3 monkeys). 
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Supplementary Figures 
Supplementary Figure 1: a) Retinal pigment epithelial cell and choriocapillaris morphology 
at 8AM (left panel) and b) 8PM (right panel). 
 
Supplementary Figure 2: a) Occludin transcript expression at 8AM compared to 8PM (*P < 
0.05). b) Occludin expression following circadian inversion. c) ZO-1 expression at 8AM 
compared to 8PM (*P < 0.05) (n = 3 independent experiments). d) ZO-1 expression 
following circadian inversion. 
 
Supplementary Figure 3: a) Fundus fluorescein angiography (FFA) analysis in 129 mice at 
8AM (top panels) compared to 8PM (bottom panels).  Significant sodium fluorescein signal 
observed at 8PM (right panel), ***P < 0.001, (n = 10 for 8AM, n = 8 for 8PM). b) FFA 
analysis in CD1 mice at 8AM (top panels) compared to 8PM (bottom panels).  Significant 
sodium fluorescein signal observed at 8PM (right panel), ***P < 0.001, (n = 5). 
 
Supplementary Figure 4: Fundus fluorescein angiography (FFA) analysis in Bmal1WT/f.Cre+ 
mice at 8AM (top panels) compared to 8PM (bottom panels), with no significant differences 
observed (right panel). (n= 20 for both time points). 
 
